Filing Details
- Accession Number:
- 0001842952-21-000027
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-12-17 16:18:34
- Reporting Period:
- 2021-10-22
- Accepted Time:
- 2021-12-17 16:18:34
- Original Submission Date:
- 2021-10-22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1842952 | Context Therapeutics Inc. | CNTX | Pharmaceutical Preparations (2834) | 472566423 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861989 | A. Martin Lehr | 3675 Market Street Suite 200 Philadelphia PA 19104 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-22 | 52,680 | $7.14 | 0 | No | 4 | O | Indirect | Martin Lehr 2000 Trust |
| Common Stock | Acquisiton | 2021-10-22 | 210,715 | $0.00 | 210,715 | No | 4 | C | Indirect | Martin Lehr 2000 Trust |
| Common Stock | Acquisiton | 2021-10-22 | 586,475 | $0.00 | 797,190 | No | 4 | C | Indirect | Martin Lehr 2000 Trust |
| Common Stock | Acquisiton | 2021-10-22 | 10,000 | $5.00 | 807,190 | No | 4 | P | Indirect | Martin Lehr 2000 Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | O | Indirect | Martin Lehr 2000 Trust |
| No | 4 | C | Indirect | Martin Lehr 2000 Trust |
| No | 4 | C | Indirect | Martin Lehr 2000 Trust |
| No | 4 | P | Indirect | Martin Lehr 2000 Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Acquisiton | 2021-10-22 | 52,680 | $0.00 | 52,680 | $7.14 |
| Common Stock | Series A Preferred Stock | Disposition | 2021-10-22 | 210,715 | $0.00 | 210,715 | $0.00 |
| Common Stock | Series Seed Preferred Stock | Disposition | 2021-10-22 | 586,475 | $0.00 | 586,475 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-20 | 2030-12-20 | No | 4 | O | Indirect |
| 7 | No | 4 | C | Indirect | ||
| 1 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 89,583 | Direct |
Footnotes
- Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- Fully vested.
Billionaire Hedge Funds
